chr8-133040017-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001045556.3(SLA):c.598G>A(p.Asp200Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000902 in 1,551,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001045556.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLA | NM_001045556.3 | c.598G>A | p.Asp200Asn | missense_variant | 8/9 | ENST00000338087.10 | NP_001039021.1 | |
TG | NM_003235.5 | c.7239+9994C>T | intron_variant | ENST00000220616.9 | NP_003226.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLA | ENST00000338087.10 | c.598G>A | p.Asp200Asn | missense_variant | 8/9 | 1 | NM_001045556.3 | ENSP00000337548.5 | ||
TG | ENST00000220616.9 | c.7239+9994C>T | intron_variant | 1 | NM_003235.5 | ENSP00000220616.4 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152138Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000357 AC: 5AN: 1399476Hom.: 0 Cov.: 34 AF XY: 0.00000145 AC XY: 1AN XY: 690264
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152138Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2024 | The c.718G>A (p.D240N) alteration is located in exon 6 (coding exon 6) of the SLA gene. This alteration results from a G to A substitution at nucleotide position 718, causing the aspartic acid (D) at amino acid position 240 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at